Begell House Inc
DANBURY, CT and LONDON, UK / ACCESSWIRE / September 18, 2023 / Hexxcell Ltd., a global leader in advanced software solutions for heat exchangers, and Begell House Inc., renowned scholarly publishers in thermal engineering and computational sciences, jointly celebrate the resounding success of their innovative Heat Exchanger Design Handbook (HEDH) Webinar Series.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Launched in April, this webinar series connects researchers, engineers, educators and industry professionals from various sectors to discuss the latest advancements, best practices, and emerging trends in heat exchanger design, optimization and maintenance. Recordings of all webinars are available at https://hedhme.com/webinars/.
Examining Practical Challenges in Heat Transfer
The series kicked off with the highly anticipated session on " Developing a Route to Net-zero Carbon Emissions for the Process Industry" with Professor Robin Smith from the University of Manchester. Other presenters touched on a variety of hot topics; Dr. Hans Borgt, industrial cleaning specialist from the Dow Chemical Company, discussed proper cleaning methods and procedures for heat exchangers, while Dr. Les Jackowski, a top heat exchanger consultant from the Bay Area's Chevron Technical Center (CTC), reviewed the "Operational Issues Caused by Incorrect Heat Exchanger Design Choices".
Dr. Francesco Coletti, CEO of Hexxcell Ltd. and Executive Editor of HEDH, expressed his enthusiasm about the collaboration: "By bringing to our readers leading experts from both academia and industry discussing timely topics in heat transfer and heat exchangers, our goal is to create a platform for knowledge exchange that bridges the gap between theoretical knowledge and practical applications. We believe that by attending the seminars, participants will gain unique perspectives and a deeper understanding of heat transfer principles and their real-world implications."
Yelena Shafeyeva, President of Begell House, also shared her excitement, stating that "The feedback has been overwhelmingly positive from both seasoned engineers and academic faculty, who recognize these webinars as a valuable teaching tool for undergraduate and post-graduate students preparing to enter the industry."
Begell House and Hexxcell first joined forces more than 10 years ago to reinvent Begell's flagship publication, the Heat Exchanger Design Handbook (HEDH), as a revolutionary and fully interactive digital platform. Achieved in 2016, the dynamic HEDH Multimedia Edition has since become the go-to reference source for heat exchanger design and heat transfer applications, serving academic and industrial users globally.
Register for the Next Webinar
Building on the series' past successes, Hexxcell and Begell House are thrilled to announce the next webinar slated for September 26th. Entitled "How Heat Exchangers Foul and How to Design Effectively", industry expert Dr. Himanshu Joshi will shed light on the commonly overlooked issue of fouling in heat exchangers and offer effective design strategies to mitigate its effects.Registration for the upcoming webinar is now open. To reserve your spot, visit bit.ly/45GXrso and follow #HEDHWebinarSeries on social media platforms for event updates.
Media Contact:
Meghan Rohrmann
Marketing Manager
Begell House Inc. Publishers
+1-203-456-6161
Meghan@begellhouse.com
ABOUT BEGELL HOUSE INC:
International leading publisher Begell House Inc. has been providing forefront research and advancements to scientific, technical, and medical communities for over 30 years. As a trusted source of engineering and biomedical research for education, R&D and industrial developments, their extensive collection of peer-reviewed journals, eBooks, databases and conference papers covers mechanical engineering, thermodynamics, energy, materials and environmental sciences, telecommunications, AI/ML computational, biomedical engineering, and cancer research. With a global network of editors, authors, reviewers, and subscribers, Begell House advances scientific understandings on important issues, while creating open discussions and possible solutions for researchers in both academia and industry. For more information, visit https://www.begellhouse.com/ or follow Begell House Inc. on LinkedIn, Facebook and X (Twitter).
ABOUT HEXXCELL LTD:
Hexxcell Ltd. is a London based software and consulting company whose mission is to bring digital innovation to industrial heat transfer systems, helping customers to decarbonise their operations, improve asset availability, debottleneck production and to deliver long-lasting positive impact through their Industry 4.0 digitalization journey. Hexxcell's Hybrid Digital Twin (HDT) technology combines Artificial Intelligence (AI) with rigorous physics-based models and deep domain knowledge for Advanced Monitoring, Predictive Analytics and Prescriptive Maintenance of industrial thermal systems. It is currently being used by customers worldwide to increase production and energy efficiency, mitigate fouling, optimally manage cleaning of heat exchangers, reduce fuel consumption and CO2 emissions. For more information, visit https://www.hexxcell.com/ or follow Hexxcell on LinkedIn and X (Twitter).
SOURCE: Begell House Inc.
View source version on accesswire.com:
https://www.accesswire.com/784535/begell-house-inc-and-hexxcell-ltd-celebrate-the-success-of-their-new-heat-exchanger-design-handbook-webinar-series
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC12.1.2026 13:00:00 CET | Press release
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has entered into a commercial license agreement with TegMine Therapeutics, Inc. (TegMine), a San Francisco-based biopharma focused on developing antibodies targeting cancer-associated glycans and glycoproteins, for a glycan-targeting ADC. Under the terms of the agreement, OBI is eligible to receive an upfront payment as well as development and commercial milestones. Following product launch, OBI will also receive royalties based on a tiered percentage of annual net sales. While the detailed financial terms are not disclosed in accordance with the confidentiality provisions, the overall deal economics are broadly comparable to those of recent similar licensing transactions in the market. TegMine will obtain the exclusive global rights to develop and commercialize the ADC under the license agreemen
Charlie's Holdings (OTCQB:CHUC) Signs Agreement with IKE Tech to Commercialize Transformational Age-Gated Vapes that Will Address FDA Concerns Related to Youth Access12.1.2026 12:00:00 CET | Press release
SBX Product Line Will Feature First-Ever AI-Powered Blockchain-Based Age-Gating System for Vape Products IKE's patented biometric BLE Bluetooth chip and blockchain-based app will enable Charlie's to ensure that underage individuals will not be able to activate or utilize the Company's age-gated products. The IKE Licensing Agreement provides CHUC with a first mover advantage in youth access prevention (one of the FDA's top priorities) and a three-year exclusivity period for age-gated nicotine analogue products. Charlie's will test market the IKE age-gating system this spring with the Company's popular SBX nicotine analogue product line; simultaneously, Charlie's intends to incorporate the revolutionary technology into its PACHA branded Electronic Nicotine Delivery Systems (ENDS). COSTA MESA, CA / ACCESS Newswire / January 12, 2026 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported that the Compan
Datavault AI Celebrates Successful Completion of Dream Bowl XIV, Pioneering Blockchain Innovation in Sports Entertainment12.1.2026 12:00:00 CET | Press release
On January 10, 2026, a few dozen of NFL Alumni Greats (click here for a list of participating athletes) live-autographed 100 Footballs (click here to view the autographed NFL Alumni Footballs) and 500 Jerseys (click here to view the autographed NFL Alumni Jerseys); Starting on February 1, 2026, these special, one-time, live-autographed memorabilia items are to be given away by lottery to eligible holders of Dream Bowl Meme Coin I tokens and, following their distribution date (currently set for February 21, 2026), Dream Bowl Meme Coin II tokens and will be tradable on the upcoming International NIL Exchange; $25,000 E-Sports Scholarships Raised by Sponsors were Given to Dream Bowl Madden and Team E-Sports Champions; and 70 Student Star Athletes Showcased their Talent to USFL, NFL and European League Scouts (click here to view the Special Dream Bowl XIV Participants' Jerseys). PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI
PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference9.1.2026 18:35:00 CET | Press release
MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company's Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company's lead asset PRO CAR - 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level). About PromiCell, Inc. PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 T
Datavault AI Expands IBM Collaboration to Deploy Enterprise-Grade AI at the Edge with Available Infrastructure's SanQtum AI Platform8.1.2026 13:00:00 CET | Press release
Datavault AI will activate a secured multi-city edge AI network for real-time data tokenization, security, and monetization across New York and Philadelphia NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in instant data monetization & enterprise digital twins, announced it will deliver enterprise-grade AI performance at the edge in New York and Philadelphia through an expanded collaboration with IBM using the SanQtum AI platform. Operated by Available Infrastructure, SanQtum AI is a fleet of synchronized micro edge data centers running IBM's watsonx portfolio of AI products on a zero-trust network. The combined deployment is designed to enable cybersecure data storage and compute, real-time data scoring, tokenization, and ultra-low-latency, across two of the most data-dense metro regions in the United States. By running Datavault AI's Information Data Exchange and DataScore agents - built with watsonx - within SanQtum AI's zero-trust edge e
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
